Clinical evaluation of T-AYU-HM Premium in sickle cell anemia patients: A Retrospective Study
Not Applicable
Completed
- Conditions
- Health Condition 1: D578- Other sickle-cell disorders
- Registration Number
- CTRI/2022/02/040601
- Lead Sponsor
- Dhanvantari Clinic Ayurveda Health Care Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
1.Patients were treated with T-AYU-HM Premium for sickle cell anemia at Dhanvantari Clinic between 1st January 2018 to 31st December 2020.
2.Patients with a diagnosis of Sickle Cell Anemia (SCT/SCD)
3.Patients = 5 years of age
4. Patient’s = 3 months of follow-up data available from the first treatment at the center.
5. Patient’s visited OPD of clinic regularly on scheduled appointment date
6. Patients who were hospitalized for crisis condition.
Exclusion Criteria
1.Patients who were taking other medicines for anemia
2. Pregnant and lactating women.
3. Patient’s laboratory parameters data are not available.
4. Patients follow-up is irregular
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Effect of Treatment on Complete blood counts <br/ ><br>2. Effect of Treatment on patients Symptoms <br/ ><br>Timepoint: At Baseline day 0, 30th, 90th and 120 days of treatment
- Secondary Outcome Measures
Name Time Method 1.Effect of treatment on Number of times patient was hospitalized during the study period <br/ ><br>2.Effect of treatment on Number of pain crisis episodes during treatment period <br/ ><br>3.Effect of treatment on No. of times blood transfusions required during observation period <br/ ><br>Timepoint: At Baseline day 0, 30th , 90th, 120th day of treatment